Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: The results of a Delphi consensus project

2023; Elsevier BV; Volume: 11; Issue: 2 Linguagem: Inglês

10.1016/j.ajur.2023.07.001

ISSN

2214-3890

Autores

Andrea Cocci, Marta Pezzoli, Fernando J. Bianco, F. Blefari, Pierluigi Bove, F. Cornud, Gaetano De Rienzo, P. Destefanis, D. Di Trapani, Alessandro Giacobbe, Luca Giovanessi, Antonino Laganà, Giovanni Lughezzani, Guglielmo Manenti, Gianluca Muto, Gianluigi Patelli, Novello Pinzi, Stefano Regusci, Giorgio Ivan Russo, Juan Ignacio Martínez‐Salamanca, Matteo Salvi, Luigi Silvestri, Fabrizio Verweij, Eric Walser, Riccardo Bertolo, Valerio Iacovelli, Alessandro Bertaccini, Debora Marchiori, Hugo Dávila, Pasquale Ditonno, Paolo Gontero, Gennaro Iapicca, Theo M. de Reijke, Vito Domenico Ricapito, Pierluca Pellegrini, Andrea Minervini, Sergio Serni, Francesco Sessa,

Tópico(s)

Urological Disorders and Treatments

Resumo

To evaluate transperineal laser ablation (TPLA) with Echolaser® (Echolaser® TPLA, Elesta S.p.A., Calenzano, Italy) as a treatment for benign prostatic hyperplasia (BPH) and prostate cancer (PCa) using the Delphi consensus method.

Referência(s)